Abstract
Purpose of review: The purpose of this review is to summarize recent advances in the area of genetic polymorphisms in genes affecting immunosuppressive drug bioavailability with a specific emphasis on solid organ transplantation. Recent findings: Due to recent advances in molecular techniques, there has been an abundance of publications describing genetic variability in molecules relevant to pharmacogenetics. The initial studies in the field of transplantation demonstrate some associations between polymorphisms in these candidate genes with outcomes in organ transplantation.
Keywords: Transplantation, genetic polymorphisms, immunosuppressive drug, bioavailability
Current Pharmacogenomics
Title: Genomic Strategies in Transplantation “The Right Drug for the Right Patient”
Volume: 2 Issue: 2
Author(s): Bernd Schroppel
Affiliation:
Keywords: Transplantation, genetic polymorphisms, immunosuppressive drug, bioavailability
Abstract: Purpose of review: The purpose of this review is to summarize recent advances in the area of genetic polymorphisms in genes affecting immunosuppressive drug bioavailability with a specific emphasis on solid organ transplantation. Recent findings: Due to recent advances in molecular techniques, there has been an abundance of publications describing genetic variability in molecules relevant to pharmacogenetics. The initial studies in the field of transplantation demonstrate some associations between polymorphisms in these candidate genes with outcomes in organ transplantation.
Export Options
About this article
Cite this article as:
Schroppel Bernd, Genomic Strategies in Transplantation “The Right Drug for the Right Patient”, Current Pharmacogenomics 2004; 2 (2) . https://dx.doi.org/10.2174/1570160043377600
DOI https://dx.doi.org/10.2174/1570160043377600 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
New Prospects for Nelfinavir in Non-HIV-Related Diseases
Current Molecular Pharmacology Design of multifunctional nanocarriers for delivery of anti-cancer therapy
Current Pharmaceutical Design The Contribution of Extracellular Nef to HIV-Induced Pathogenesis
Current Drug Targets Nanoparticles based on oleate alginate ester as curcumin delivery system
Current Drug Delivery Recent Advances on Small-Molecule Survivin Inhibitors
Current Medicinal Chemistry Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Editorial (Thematic Issue: Chemoresistance in Gynecologic Cancers)
Current Cancer Therapy Reviews Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders
Current Cancer Therapy Reviews Nanoceria: A Novel Cytoprotective Drug Delivery Carrier
Current Nanomedicine Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Intelligent Drug Delivery Systems Based on Modified Chitosan Nanoparticles
Letters in Organic Chemistry Traditional Uses, Phytochemistry, Pharmacology and Anticancer Activity of Açaí (Euterpe oleracea Mart): A Narrative Review
Current Traditional Medicine Drugs Acting on the Beta Isoform of Human Topoisomerase II (p180)
Current Medicinal Chemistry - Anti-Cancer Agents The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy
Current Cancer Drug Targets Metal Complexes of Natural Product Like-compounds with Antitumor Activity
Anti-Cancer Agents in Medicinal Chemistry The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets